Abstract
Because of the low incidence of penile carcinoma (PC), the value of p16(ink4a), p53, and human papilloma virus (HPV) infection status in clinical practice remains unclear. Herein, we report our experience with potential clinical utility of these markers in men with PC treated at our institution. Tissue microarrays of 57 cases of invasive penile squamous cell carcinomas were immunohistochemically stained for p16 and p53. HPV in situ hybridization (ISH) for high-risk subtypes was also performed. Association between marker status, nodal disease, overall (OS) and cancer-specific survival (CSS) were assessed. p16 and HPV ISH were positive in 23 (40%) and 24 (42%) of the cohort, respectively. The proportion of warty, basaloid, or mixed warty basaloid tumor subtypes were significantly greater in the p16-positive patients (48% vs. 3%; P < .01). p53 expression was negative in 31 (54%) cases. Only in p16-negative patients, positive p53 status was associated with pN+ disease (odds ratio, 4.4 [95% confidence interval (CI), 1.04-18.6]). In Kaplan-Meier analysis, the unadjusted estimated OS was insignificantly longer in p16-positive patients (median OS, 75 vs. 27 months; P = .27) and median CSS was not reached (P = .16). In a multivariable C...Continue Reading
References
Apr 6, 1990·Science·B A WernessP M Howley
Jun 7, 2002·The Journal of Urology·Ademar LopesLuisa Lina Villa
Jul 3, 2003·Medical Microbiology and Immunology·G Gross, H Pfister
Sep 2, 2003·The Journal of Pathology·Emmanuelle FerreuxPeter J F Snijders
Jan 17, 2007·Oncogene·S CamusD P Lane
May 1, 2007·The Lancet Oncology·Oliver KayesSuks Minhas
Dec 17, 2008·Cancer Causes & Control : CCC·Danielle M BackesJennifer S Smith
Feb 27, 2010·Cancer·Aatur D Singhi, William H Westra
Nov 4, 2010·BJU International·Peter KirranderMats Karlsson
Mar 5, 2013·World Journal of Urology·Jian-Ye LiuFang-Jian Zhou
Mar 12, 2013·Journal of the American Academy of Dermatology·Sebastian MannweilerSigrid Regauer
Aug 7, 2013·The Journal of Urology·Rosa S DjajadiningratSimon Horenblas
Aug 26, 2014·The Journal of Urology·Rosa S DjajadiningratDaniëlle A M Heideman
Sep 28, 2014·The Journal of Urology·Dominic H TangLan L Gellert
Dec 3, 2014·European Urology·Oliver W HakenbergNick Watkin
Citations
Apr 14, 2017·Journal of Medical Virology·Larissa Alves AfonsoSilvia Maria Baeta Cavalcanti
Jan 26, 2017·Oncotarget·Hellen KuasneSilvia R Rogatto
Mar 29, 2018·World Journal of Urology·Zhigang YuanPeter A Johnstone
Jun 9, 2018·Cell Death & Disease·Qiang-Hua ZhouRan-Yi Liu
Oct 24, 2019·BMC Veterinary Research·Anna Sophie RamsauerPaula Grest
Aug 20, 2020·Nature Reviews. Urology·Ahmet Murat AydinPhilippe E Spiess
May 7, 2020·PloS One·Valquíria do Carmo Alves MartinsKátia Luz Torres
Aug 15, 2018·BioMed Research International·Jiayi ZhangNinghong Song
Oct 22, 2020·Journal of Clinical Medicine·Mohamed E AhmedPhilippe E Spiess
Jul 11, 2018·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Freja Lærke SandSusanne K Kjaer
Apr 2, 2021·Infectious Agents and Cancer·Federica Zito MarinoRenato Franco
Apr 7, 2021·Annales de pathologie·Eva Compérat, Philippe Moguelet
Aug 6, 2021·Clinical Genitourinary Cancer·Sambit K MohantyAnil V Parwani
Jul 6, 2021·Urologic Oncology·Timothy A Masterson, Scott T Tagawa
Dec 24, 2021·Nature Reviews. Urology·Marco BandiniPhilippe E Spiess